Sign In
Buy MRVI
$4.84
+0.0100 (+0.207%)
At Close: Jun 03, 2026
Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2023 Earnings Call Transcript
12:00am, Friday, 23'rd Feb 2024
Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2023 Earnings Call Transcript
Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results
04:05pm, Thursday, 22'nd Feb 2024
Continued Focus on Expanding Product Portfolio, Market Leadership and Innovation Continued Focus on Expanding Product Portfolio, Market Leadership and Innovation
3 Doomed Biotech Stocks to Dump Before They Dive: February 2024
05:00pm, Sunday, 11'th Feb 2024
The unpredictable nature of the biotech industry, which frequently flirts with failure, underscores the inherent risks and rewards associated with doomed biotech stocks. The journey from drug discover
Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024
08:00am, Monday, 29'th Jan 2024
SAN DIEGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t
Maravai LifeSciences Announces November 2023 Investor Conference Schedule
08:15am, Thursday, 09'th Nov 2023
SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to p
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2023 Earnings Call Transcript
03:54am, Wednesday, 08'th Nov 2023
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ET Company Participants Deb Hart - Investor Relations Trey Martin - Chief Executive Officer
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023
08:15am, Tuesday, 17'th Oct 2023
SAN DIEGO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t
Maravai LifeSciences Hosts 2023 Investor R&D Day
08:15am, Friday, 29'th Sep 2023
Highlights include the company's strong foundation for growth, focus on innovation and attractive long-term outlook Highlights include the company's strong foundation for growth, focus on innovation a
Maravai LifeSciences Chief Innovation Officer Kate Broderick Named to 2023 PharmaVoice 100
09:31am, Tuesday, 19'th Sep 2023
SAN DIEGO, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced
Maravai LifeSciences to Host 2023 Investor R&D Day
04:15pm, Tuesday, 05'th Sep 2023
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovator
Cygnus Technologies Receives 2023 R&D 100 Award for MockV® RVLP Kit
08:15am, Wednesday, 23'rd Aug 2023
LELAND, N.C., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading product and services provider for the detection and characteriza
Maravai LifeSciences Announces August 2023 Investor Conference Schedule
04:15pm, Wednesday, 09'th Aug 2023
SAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to p
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2023 Earnings Call Transcript
04:36am, Tuesday, 08'th Aug 2023
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q2 2023 Earnings Call Transcript August 7, 2023 5:00 PM ET Company Participants Debra Hart - Head of IR Carl Hull - Executive Chairman of the Board T
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 7, 2023
04:05pm, Monday, 24'th Jul 2023
SAN DIEGO, July 24, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2023 Earnings Call Transcript
07:52pm, Monday, 08'th May 2023
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Chairman of the Board
